M&A / Deals Syneron raises $150m for macrocyclics, and other financings PharmaphorumOur round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.M&A / DealsRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder. M&A / DealsRead full story Post navigation Previous: Shionogi secures $482m BARDA contract to tackle AMR crisisNext: FDA seeks permanent future for rare pediatric priority review vouchers Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026